/
We are a leading global manufacturer in the design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. Our products include a variety of primary proprietary packaging, containment solutions, reconstitution and transfer systems, and drug delivery systems, as well as contract manufacturing, ana…
19.03% operating margin is respectable but not wide. ROIC at 14.28%. Suggests the business covers its cost of capital, but doesn't point to a wide moat.
Revenue grew 6.3%, steady but not accelerating.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Profitability & Returns
Revenue (TTM)
$3.22B
▲ +6.3% YoY
Net Income (TTM)
$543M
▲ +0.2% YoY
Op. Margin
20.34%
▼ -0.7pp YoY
ROIC
15.30%
▼ -0.7pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$458M
▲ +69.6% YoY
Op. Cash Flow (TTM)
$715M
▲ +15.5% YoY
Net Debt
-$200M
Net Cash Position
Cash & Equiv.
$521M
5Y CAGR: +7.4%
5Y CAGR: +9.5%
Continue Research